Home > Financial Ratios > AARTI PHARMALABS

AARTI PHARMALABS
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for AARTI PHARMALABS
Please provide your vote to see the results

AARTI PHARMALABS Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) 21.9620.8417.5817.11-

What is the latest Core EBITDA Margin ratio of AARTI PHARMALABS ?

The latest Core EBITDA Margin ratio of AARTI PHARMALABS is 21.96 based on Mar2025 Consolidated results.
Year Core EBITDA Margin
Mar202521.96
Mar202420.84
Mar202317.58
Mar202217.11
Mar2021-

How is Core EBITDA Margin of AARTI PHARMALABS Trending?

Years Core EBITDA Margin % Change
Mar2025 21.96
5.37
Mar2024 20.84
18.54
Mar2023 17.58
2.75
Mar2022 17.11
0
Mar2021 0 -

Other Financial Ratios of AARTI PHARMALABS


Compare Core EBITDA Margin ratio of peers of AARTI PHARMALABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI PHARMALABS ₹7,642.6 Cr -1.4% -3.2% 41.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,804.0 Cr 0.3% 4.1% -9.9% Stock Analytics
DIVIS LABORATORIES ₹170,764.0 Cr -1.7% 8.5% 13.2% Stock Analytics
CIPLA ₹126,807.0 Cr -3.4% 3% 4.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,099.0 Cr 0.7% -0.5% 7.2% Stock Analytics
DR REDDYS LABORATORIES ₹107,707.0 Cr 0.2% -1.1% -3.6% Stock Analytics


AARTI PHARMALABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI PHARMALABS

-1.4%

-3.2%

41.4%

SENSEX

0.3%

3.6%

5.5%


You may also like the below Video Courses